MEDEQUITIES RT Revenue, Profits - MRT Quarterly Income Statement

Add to My Stocks
$9.86 $0.22 (2.28%) MRT stock closing price Sep 18, 2018 (Closing)

MRT stock valuation based on fundamental analysis involves checking and analyzing financial statements and not just the MEDEQUITIES RT stock price. The income statement gives the investor an understanding of the topline or revenue and bottomline or profit numbers of the company and helps investors evaluate if a company has been growing or not. Like any other income statement, the MRT income statement also itemizes revenue/sales, operating expenses, and profits/bottomline for a quarter or year and reflects a QoQ revenue growth of 5.02% when compared to the same period in the past. Along with MEDEQUITIES RT assets and MEDEQUITIES RT free cash flow, MEDEQUITIES RT profits as shown in profit and loss statement give key insights about the business. The net profit for 2018 Q2 is $3.23M and the 2018 Q2 revenue is $17.56M.

View and download details of revenue and profits for MEDEQUITIES RT for latest & last 40 quarters.
show more
Quarterly
Annual
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec2018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q1
MEDEQUITIES RT Revenues or Net Sales
17.56M16.72M16.23M15.77M14.83M14.28M14.01M13.85M6.59M14.84M
Cost Of Goods Sold (COGS)1.17M---------
MEDEQUITIES RT Gross Profit
16.39M16.32M15.85M15.39M14.4M13.84M13.58M13.41M6.21M14.42M
Research & Development Expense----------
Selling General & Admin Expense5.24M3.42M2.59M3.07M3.24M3.23M2.85M2.46M3.21M2.78M
Income Before Depreciation Depletion Amortization11.15M12.89M13.27M12.31M11.16M10.6M10.74M10.95M3M11.63M
Depreciation Depletion Amortization4.18M4.19M4.34M3.93M3.62M3.61M3.64M3.61M3.42M3.65M
Non Operating Income----------
Interest Expense2.79M2.55M2.28M2.11M1.8M1.51M1.75M2.79M3.22M3.12M
MEDEQUITIES RT Pretax Income
4.19M6.15M6.69M6.26M5.73M5.47M5.37M4.73M-3.64M4.85M
Provision for Income Taxes----------
MinorityInterest---------2.84M1.35M
Investment Gains Losses----------
Other Income----------
Income Before Extraordinaries & Disc Operations4.19M5.17M5.77M6.27M4.8M4.53M5.38M3.91M-3.64M4.85M
Extraordinary Items & Discontinued Operations----------
MEDEQUITIES RT Profit/ Loss (Net Income)
3.23M5.17M5.77M6.27M4.8M4.53M5.38M3.91M-0.8M3.49M
Average Shares used to compute Diluted EPS31.63M31.61M31.55M31.51M31.49M31.42M30.36M10.96M--
Average Shares used to compute Basic EPS31.55M31.55M31.5M31.47M31.4M31.42M30.36M10.96M--
Income Before Nonrecurring Items3.23M5.17M5.77M6.27M4.8M4.53M5.38M3.91M--
Income from Nonrecurring Items----------
MEDEQUITIES RT Earnings Per Share Basic Net
0.100.160.180.170.150.14-0.060.12--
MEDEQUITIES RT Earnings Per Share Diluted Net
0.100.160.180.170.150.14-0.060.12--
EPS Diluted Before Nonrecurring Items0.100.160.180.170.150.14-0.060.12--
Preferred Dividends Acc Pd----------
Dividends Common6.706.706.67-------
Dividend Per Share Common0.210.210.210.210.210.210.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters

MEDEQUITIES RT stock analysis involves checking at least a few of the important things like:

  • Revenue: This is the inflow that is generated from the sale of goods or services and is $17.56M for this quarter of 2018 Q2. Our MEDEQUITIES RT revenue chart gives a clear visual representation of how the topline or sales growth has been. Investors often invest only in those companies where the revenue is growing at a steady rate.
  • Bottom line: This refers to the last line in a profit and loss statement and denotes the net profit or loss for a particular period. The figure currently stands at $3.23M for MEDEQUITIES RT for 2018 Q2. This figure is arrived at after deducting all operating expenses, interest, and taxes from revenue.

The income statement is also called statement of revenue and expense. The MRT financials along with MEDEQUITIES RT historical stock prices provide a lot of details about the firm.

MEDEQUITIES RT Income Statement - Key Financial Ratios

PE Ratio (price earnings ratio)
16.16
PS Ratio (price sales ratio)
4.69
Operating Margin
39.7
Net Profit Margin
18.4
Dividend Yield
8.52%